Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBUMP.L Regulatory News (BUMP)

  • There is currently no data for BUMP

CORRECTION Director/PDMR Shareholding

14 Oct 2021 07:00

RNS Number : 0136P
Seraphine Group PLC
13 October 2021
 

SERAPHINE GROUP PLC

(the "Company")

CORRECTION Director/ PDMR Shareholding

13 October 2021

This is a correction of the announcement released 23 September 2021 (13:23). The reason for the correction is the total number of shares held by David Williams following the acquisition of shares was incorrectly calculated and should have read:

"Following the acquisition of the shares, David Newton Williams holds 1,849,523 Ordinary Shares in the Company."

This Notification is made in accordance with the requirements of Article 19 of the EU Market Abuse Regulation, the Notification of Dealing Form for the PDMR can be found below. 

For Further information please contact:

Seraphine Group PLC

David Williams, Chief Executive Officer

Bridget Green, General Counsel

Ian Hinckley, Investor Relations

 

FTI Consulting

Alex Beagley

Georgina Goodhew

Fern Duncan

Rafaella de Freitas

 

Via FI Consulting

 

 

 

 

+44 020 7260 1000

seraphine@fticonsulting.com

JTC (UK) Limited (Company Secretary)Susan Fadil

 

+44 (0) 207 409 0181

Notification of Dealing form

1

 

Details of the person discharging managerial responsibilities ("PDMR") / person closely associated ("PCA")

 

a)

 

Name

 

 

David Newton Williams

2

 

Reason for the notification

 

a)

 

Position/status

 

 

PDMR

Chief Executive Officer

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Seraphine Group PLC

b)

 

LEI

 

 

254900CQ8TMKUDD0L296

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

 

Identification code

 

Ordinary Shares

 

 

ISIN: GB00BNXGTY25

 

b)

 

Nature of the transaction

 

 

Subscription

 

 

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

 200.5p

125,000

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

- Price

 

 

 

125,000 ordinary shares in aggregate

 

£250,625

e)

 

Date of the transaction

 

 

23 September 2021

f)

 

Place of the transaction

 

 

London Stock Exchange

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBIBDGXBBDGBX
12
Date   Source Headline
28th Jul 20227:00 amRNSNotice of Results
14th Jul 202211:19 amRNSNotification of Major Holdings
25th May 20225:03 pmRNSNotification of Major Holdings
24th May 20225:26 pmRNSNotification of Major Holdings
13th May 202210:03 amRNSNotification of Major Holdings
5th May 20227:00 amRNSYear End Trading Update
24th Mar 20224:23 pmRNSHolding(s) in Company
24th Mar 20224:21 pmRNSHolding(s) in Company
1st Mar 20227:00 amRNSDirector/PDMR Shareholding
23rd Feb 20227:00 amRNSTrading Update
6th Jan 20223:08 pmRNSHolding(s) in Company
22nd Dec 20217:00 amRNSCFO Appointment
14th Dec 20217:00 amRNSDirector/PDMR Shareholding
9th Dec 20217:00 amRNSInterim Results
25th Nov 20214:46 pmRNSHolding(s) in Company
14th Oct 20217:00 amRNSCORRECTION Director/PDMR Shareholding
14th Oct 20217:00 amRNSCORRECTION Director/PDMR Shareholding
23rd Sep 20211:36 pmRNSDirector/PDMR Shareholding
23rd Sep 20211:23 pmRNSDirector/PDMR Shareholding
23rd Sep 20217:00 amRNSTrading Statement
20th Aug 202112:50 pmRNSHolding(s) in Company - TR1 Notification
21st Jul 20217:00 amRNSHolding(s) in Company
19th Jul 20215:34 pmRNSHolding(s) in Company
19th Jul 20215:30 pmRNSHolding(s) in Company - TR1 Notification
19th Jul 20215:29 pmRNSHolding(s) in Company - TR1 Notification
19th Jul 20212:10 pmRNSHolding(s) in Company
19th Jul 20217:00 amRNSDirector/PDMR Shareholding - Grant of LTIP Awards
16th Jul 20217:00 amRNSAdmission to Trading on the London Stock Exchange
13th Jul 20211:28 pmRNSApproval and Publication of Prospectus
13th Jul 20217:00 amRNSAnnouncement of Offer Price
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.